Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Novartis AG ADR
NVSEFCurrent price
109.7 USD
0 USD (0.00%)
Last closed
113.77 USD
Company
www.novartis.com
ISIN
US66987V1098
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
NYSE
Capitalization
232 151 089 152 USD
Yield for 12 month
+18.51 %
1Y
3Y
5Y
10Y
15Y
NVSEF
Novartis AG engages in the research, development, manufacture, and marketing of healthcare products in Switzerland and internationally. The company offers prescription medicines for patients and physicians. The company also provides Pluvicto, lutetium Lu 177 vipivotide tetraxetan, indicated for the treatment of adult patients with prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer; and Lutathera, lutetium Lu 177 dotatate, a prescription medicine used to treat adults and children aged 12 years and older with gastroenteropancreatic neuroendocrine tumors. It focuses on therapeutic areas, such as cardiovascular, renal and metabolic, immunology, neuroscience, and oncology, as well as ophthalmology and hematology. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol; and Dawn Health for the development and commercialization of Ekiva, a digital solution designed for people living with Paroxysmal Nocturnal Hemoglobinuria. The company was incorporated in 1996 and is headquartered in Basel, Switzerland. Address: Lichtstrasse 35, Basel, Switzerland, 4056
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
117.9 USDP/E ratio
23.2658Dividend Yield
3.32 %Current Year
+46 660 000 000 USD
Last Year
+51 828 000 000 USD
Current Quarter
+12 512 000 000 USD
Last Quarter
+11 829 000 000 USD
Current Year
+34 188 000 000 USD
Last Year
+36 342 000 000 USD
Current Quarter
+9 295 000 000 USD
Last Quarter
+8 699 000 000 USD
Key Figures NVSEF
1 year
3 years
5 years
10 years
EBITDA
19 296 000 000 USD
Operating Margin TTM
PE Ratio
23.2658
Return On Assets TTM
8.86 %
PEG Ratio
1.7287
Return On Equity TTM
21.5 %
Wall Street Target Price
117.9 USD
Revenue TTM
48 860 000 256 USD
Book Value
20.61 USD
Revenue Per Share TTM
Dividend Share
3.92 USD
Quarterly Revenue Growth YOY
9.6 %
Dividend Yield
3.32 %
Gross Profit TTM
36 744 000 000 USD
Earnings per share
4.89 USD
Diluted Eps TTM
4.89 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
43 %
Profit Margin
33.11 %
Dividend Analytics NVSEF
Dividend growth over 5 years
30 %Continuous growth
2 yearsPayout Ratio 5 years average
80 %Dividend History NVSEF
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
3.78
Ex Dividend Date
07.03.2024
Forward Annual Dividend Yield
3.32 %
Last Split Factor
1116:1000
Payout Ratio
52.97 %
Last Split Date
09.04.2019
Dividend Date
19.04.2024
Stock Valuation NVSEF
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
23.2658
Forward PE
14.0056
Enterprise Value Revenue
5.1924
Price Sales TTM
4.7514
Enterprise Value EBITDA
13.3667
Price Book MRQ
5.5193
Financials NVSEF
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators NVSEF
For 52 weeks
88.8 USD
120.92 USD
50 Day MA
115.13 USD
Shares Short Prior Month
5 870 494
200 Day MA
105.36 USD
Short Ratio
5.08
Shares Short
5 323 078
Short Percent
0.26 %
BeatStart